Front-Row-Advisors

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
512
Total Value
260225274
Accession Number
0001729254-25-000003
Form Type
13F-HR
Manager Name
Front-Row-Advisors
Data Enrichment
66% identified
336 identified176 unidentified

Holdings

512 positions • $260.2M total value
Manager:
Search and click to pin securities to the top
Page 26 of 26
CONDUENT Inc
Shares:20
Value:$54
% of Portfolio:0.0% ($54/$260.2M)
852234103
Shares:1
Value:$54
% of Portfolio:0.0% ($54/$260.2M)
FORD MOTOR CO
Shares:5
Value:$50
% of Portfolio:0.0% ($50/$260.2M)
Organon & Co.
Shares:3
Value:$47
% of Portfolio:0.0% ($47/$260.2M)
140755208
Shares:6
Value:$30
% of Portfolio:0.0% ($30/$260.2M)
Lumen Technologies, Inc.
Shares:7
Value:$27
% of Portfolio:0.0% ($27/$260.2M)
EKSO BIONICS HOLDINGS, INC.
Shares:31
Value:$12
% of Portfolio:0.0% ($12/$260.2M)
AGENUS INC
Shares:5
Value:$8
% of Portfolio:0.0% ($8/$260.2M)
Cardiff Oncology, Inc.
Shares:2
Value:$6
% of Portfolio:0.0% ($6/$260.2M)
GT Biopharma, Inc.
Shares:1
Value:$2
% of Portfolio:0.0% ($2/$260.2M)
RELMADA THERAPEUTICS, INC.
Shares:6
Value:$2
% of Portfolio:0.0% ($2/$260.2M)
33616C100
Shares:325
Value:$1
% of Portfolio:0.0% ($1/$260.2M)